Atlas Trials

Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients

Clinical trial NCT00080197 · COMPLETED

Trial details

NCT number
NCT00080197
Sponsor
Eisai Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast NeoplasmsMetastases
Start date
2004-02-01
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.